The placebo effect in cardiovascular disease

American Heart Journal
L BienenfeldS P Glasser

Abstract

The effect of placebo on the clinical course of systemic hypertension, angina pectoris, silent myocardial ischemia, CHF, and ventricular tachyarrhythmias has been well described. In the prevention of myocardial infarction, there appears to be a direct relation between compliance with placebo treatment and favorable clinical outcomes. The safety of short-term placebo-controlled trials has now been well documented in studies of drug treatment of angina pectoris. Although the ethical basis of performing placebo-controlled trials continues to be challenged in the evaluation of drugs for treating cardiovascular disease, as long as a life-saving treatment is not being denied it remains prudent to perform placebo-controlled studies for obtaining scientific information.

References

Jan 1, 1976·Perspectives in Biology and Medicine·H Byerly
May 17, 1975·British Medical Journal·L HanssonA Westerlund
Jul 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·J D LevineH L Fields
Jun 1, 1977·British Journal of Clinical Pharmacology·P R Wilkinson, E B Raftery
Jun 23, 1975·JAMA : the Journal of the American Medical Association·H Benson, M D Epstein
Jan 1, 1992·Cardiology·T P Archer, C V Leier
Apr 1, 1991·Journal of Hypertension·E MuttiG Mancia
Nov 15, 1991·Journal of the American College of Cardiology·R J CaponeA L Waldo
Dec 1, 1990·American Heart Journal·M Packer
Aug 10, 1989·The New England Journal of Medicine·UNKNOWN Cardiac Arrhythmia Suppression Trial (CAST) Investigators
Jun 1, 1989·Cardiovascular Drugs and Therapy·A J CoatsP Sleight
Feb 10, 1988·The American Journal of Cardiology·G ParatiG Mancia
Jul 1, 1987·British Journal of Clinical Pharmacology·A G DupontR O Six
Jan 1, 1987·The American Journal of Cardiology·J MorganrothG Chao
Sep 1, 1969·The American Journal of Cardiology·E A AmsterdamR Gorlin
Feb 1, 1995·British Journal of Clinical Pharmacology·M D DriciP Gustovic
May 25, 1994·JAMA : the Journal of the American Medical Association·J A TurnerW E Fordyce
Jan 5, 1995·The New England Journal of Medicine·S Cagliano, G Traversa
Dec 12, 1994·Archives of Internal Medicine·R J GlynnC H Hennekens
Oct 1, 1993·Controlled Clinical Trials·B R DavisJ L Probstfield
May 1, 1993·Oral Surgery, Oral Medicine, and Oral Pathology·E V HershA Barasch
May 22, 1954·Journal of the American Medical Association·S WOLF, R H PINSKY
Jun 1, 1954·The American Journal of Medicine·L LASAGNAH K BEECHER
Aug 1, 1956·Circulation·H CHASISH W SMITH
Apr 1, 1960·The American Journal of Cardiology·E G DIMONDJ E CROCKETT

❮ Previous
Next ❯

Citations

Mar 21, 2002·Journal of General Internal Medicine·A M FremontJ Z Ayanian
Dec 3, 2004·Journal of Medical Ethics·P LichtenbergU Nitzan
Oct 27, 2009·Perspectives in Biology and Medicine·Franklin G MillerTed J Kaptchuk
Mar 23, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Robert J WeissYuhua Lin
Aug 19, 2011·Journal of Behavioral Medicine·Jason P RoseStephanie L Fowler
Sep 16, 2005·Journal of Personality and Social Psychology·Andrew L GeersSuzanne G Helfer
Jul 23, 1998·Clinical and Experimental Pharmacology & Physiology·J MinamiH Matsuoka
Aug 24, 1999·Fundamental & Clinical Pharmacology·O Chassany, M Duracinský
Jul 6, 2000·Journal of Psychosomatic Research·J R Swenson, J J Clinch
Sep 22, 2001·The New England Journal of Medicine·E J Emanuel, F G Miller
Dec 12, 2012·Progress in Cardiovascular Diseases·Franklin G Miller
May 21, 2004·British Journal of Clinical Pharmacology·Robert V CarlsonDavid J Webb
Sep 22, 2006·Journal of Clinical Pharmacology·Stephen P Glasser, George Howard
Jan 27, 2010·Geriatrics & Gerontology International·E Paul Cherniack
May 5, 2004·Psychosomatics·Mark W KettererWalter Knysz
Jul 4, 1998·Lancet·A J de CraenJ Kleijnen
May 30, 2015·Chinese Medical Journal·Shun-Jie Chua, Mark Pitts
Jan 22, 2003·Journal of the American College of Cardiology·Mehrdad Saririan, Mark J Eisenberg
Feb 5, 2015·The New England Journal of Medicine·Stefan VerheyeShmuel Banai
Feb 18, 2016·Cardiology in Review·Maayan KonigsteinShmuel Banai
Jan 2, 2003·Journal of the National Cancer Institute·Gisèle Chvetzoff, Ian F Tannock
Apr 4, 2014·Journal of Evidence-based Complementary & Alternative Medicine·Kimberly M TippensCarlo Calabrese
Oct 12, 2017·European Heart Journal·Maayan KonigsteinShmuel Banai
Jan 1, 2006·Innovations : Technology and Techniques in Cardiothoracic and Vascular Surgery·Davy ChengJanet Martin
Apr 17, 2009·Quality Management in Health Care·Roman R SnihurowychVolker Eric Amelung
Mar 30, 2013·The Journal of Nervous and Mental Disease·Uri NitzanShmuel Fennig
Feb 28, 2015·The Cochrane Database of Systematic Reviews·Eduardo BrionesJosé-Ramón Rueda
Apr 28, 1999·Medizinische Klinik·T R Weihrauch
Sep 13, 2007·Forschende Komplementärmedizin = Research in Complementary Medicine·Frank Zimmermann-Viehoff, Karin Meissner
Aug 2, 2019·International Journal of Molecular Sciences·Marius Reto Bigler, Christian Seiler
Apr 22, 2021·Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology·Sérgio MadeiraManuel Almeida
Jul 1, 2021·Revista Portuguesa De Cardiologia·Sérgio MadeiraManuel Almeida

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.